Arcus Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCUS and other ETFs, options, and stocks.About RCUS
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that develop immunotherapies for the treatment of cancer.
CEOTerry J. Rosen
CEOTerry J. Rosen
Employees627
Employees627
HeadquartersHayward, California
HeadquartersHayward, California
Founded2015
Founded2015
Employees627
Employees627
RCUS Key Statistics
Market cap2.83B
Market cap2.83B
Price-Earnings ratio-6.32
Price-Earnings ratio-6.32
Dividend yield—
Dividend yield—
Average volume1.28M
Average volume1.28M
High today$22.94
High today$22.94
Low today$21.64
Low today$21.64
Open price$21.88
Open price$21.88
Volume109.55K
Volume109.55K
52 Week high$26.40
52 Week high$26.40
52 Week low$6.50
52 Week low$6.50
Stock Snapshot
The current Arcus Biosciences(RCUS) stock price is $22.87, with a market capitalization of 2.83B. The stock trades at a price-to-earnings (P/E) ratio of -6.32.
As of 2026-01-07, Arcus Biosciences(RCUS) stock has fluctuated between $21.64 and $22.94. The current price stands at $22.87, placing the stock +5.7% above today's low and -0.3% off the high.
The Arcus Biosciences(RCUS)'s current trading volume is 109.55K, compared to an average daily volume of 1.28M.
In the last year, Arcus Biosciences(RCUS) shares hit a 52-week high of $26.40 and a 52-week low of $6.50.
In the last year, Arcus Biosciences(RCUS) shares hit a 52-week high of $26.40 and a 52-week low of $6.50.
Analyst ratings
82%
of 11 ratingsBuy
81.8%
Hold
18.2%
Sell
0%
People also own
Based on the portfolios of people who own RCUS. This list is generated using Robinhood data, and it’s not a recommendation.